March 5, 2018 / 7:37 AM / 8 months ago

BRIEF-Aurobindo Pharma Says U.S. FDA Issued Form 483 With 9 Observations for Co's Unit

March 5 (Reuters) - Aurobindo Pharma Ltd:

* AUROBINDO PHARMA LTD CLARIFIES ON NEWS ITEM ON CO’S UNIT 4 GETTING 9 OBSERVATIONS AFTER U.S. FDA INSPECTION

* U.S. FDA CONDUCTED INSPECTION AT UNIT IV, HYDERABAD; AT END OF INSPECTION, CO WAS ISSUED FORM 483 WITH 9 OBSERVATIONS

* CO WOULD BE REPLYING TO FDA WITHIN 15 WORKING DAYS Source text - bit.ly/2CZTzED Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below